CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
Journal of Experimental & Clinical Cancer Research volume 41, Article number: 188 (2022)
Circular RNAs (circRNAs) are essential participants in the development and progression of various malignant tumors. Previous studies have shown that cell migration-inducing protein (CEMIP) accelerates prostate cancer (PCa) anoikis resistance (AR) by activating autophagy. This study focused on the effect of circCEMIP on PCa metastasis.
This study gradually revealed the role of circ_0004585 in PCa anoikis resistance via quantitative real-time PCR (qRT-PCR) analysis, western blotting, pull-down assays, and dual fluorescence reporter assays.
Functionally, circ_0004585 promoted PCa cells invasion and metastasis both in vitro and in vivo. Mechanistically, circ_0004585 directly interacted with miR-1248 to upregulate target gene expression. Furthermore, target prediction and dual-luciferase reporter assays identified transmembrane 9 superfamily member 4 (TM9SF4) as a potential miR-1248 target. Pathway analysis revealed that TM9SF4 activated autophagy to promote PCa cells anoikis resistance via mTOR phosphorylation.
These results demonstrated that circ_0004585 played an oncogenic role during PCa invasion and metastasis by targeting the miR-1248/TM9SF4 axis while providing new insight into therapeutic strategy development for metastatic PCa.
Anoikis is a form of programmed cell death, which is critically essential for the survival of human cancer cells after detachment from the extracellular matrix (ECM). Since aggressive anoikis-resistant cells are more likely to survive in the circulatory system, they are considered a vital prerequisite for cancer progression [1, 2]. However, the precise molecular mechanisms involved in PCa cells survival following ECM detachment remain unclear.
CEMIP, known as KIAA1199, was first described as an inner-ear-specific gene , which also played a role in developing and maintaining cancer metastasis. Recent clinical studies have shown that CEMIP increases aggressive tumor phenotypes by promoting hyaluronic acid depolymerization and the inclusion of membrane-associated clathrin in pit endocytosis [4, 5]. Furthermore, research has indicated that CEMIP is aberrantly expressed in multiple types of cancers, such as colorectal , gastric , breast , pancreatic , cervical , and liver cancer . Recent studies by our team have shown that CEMIP is upregulated in PCa and promotes its progression by regulating metabolic reprogramming . Furthermore, CEMIP promotes PCa cells anoikis resistance and metastasis by activating protective autophagy . However, the regulatory and functional mechanisms of circCMEIP in tumorigenesis and aggression remain elusive.
Circular RNAs (circRNAs) are stable, covalently closed molecules resistant to exonuclide RNase R degradation . Evidence shows that circRNAs are aberrantly expressed in gastric , colorectal , liver , PCa , and various other cancers and are essential for regulating the proliferation, migration, invasion, apoptosis, and therapeutic resistance of cancer cells [15, 19]. Moreover, circRNA acts as an endogenous sponge for miRNA to regulate target gene expression. For example, FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1-mediated autophagic response in pancreatic ductal adenocarcinoma . In addition, circRNAs may bind and sequester RNA-binding proteins (RBPs) to regulate their functionality . Research has indicated that the HNRNPL RNA binding protein facilitates circARHGAP35 formation, which is associated with poor survival rates of cancer patients . Therefore, it is crucial to understand the circRNAs mechanism in cancer progression.
This study identifies one intronic circRNA generated from the CEMIP gene as a novel regulator of CEMIP-miRNA complexes and PCa progression. Circ_0004585 is upregulated in human PCa tissues and promotes the invasion, anoikis resistance, and metastasis of PCa cells. Mechanistically, this study reveals that circ_0004585 promotes TM9SF4 expression by binding with miR-1248 to activate autophagy, enhancing PCa cell invasion, anoikis resistance, and metastasis. Therefore, circ_0004585 may serve as an oncogene to promote PCa metastasis, while this study provides a novel therapeutic target for PCa.
Materials and methods
Patient tissue specimens and cell lines
A total of 60 sets of PCa tissue specimens and their corresponding normal prostate tissues were obtained from patients who underwent prostatectomy for PCa at the Department of Urology of the Union Hospital affiliated with Tongji Medical College between 2015 and 2019. Before sample collection, approval was obtained from the Institutional Review Board of the Tongji Medical College of the Huazhong University of Science and Technology. All specimens were classified according to the 2004 World Health Organization Consensus Classification and Staging System for prostate neoplasms. The anoikis-resistance model and cell culture were established using human androgen-independent PCa cell lines, PC-3 and DU145, which were obtained from the Shanghai Cell Bank, Chinese Academy of Sciences (Shanghai, China). Androgen-dependent C4–2 and LNCaP cell lines were donated by Prof. Xiaoping Zhang and Professor Jun Zhao (Union Hospital, Wuhan, China). The prostatic epithelial cell line RWPE-1 and androgen-dependent 22RV1 were obtained from the China Center for Type Culture Collection, CCTCC (Wuhan, China). The cells were maintained in RPMI 1640 medium (Hyclone, GE Healthcare Life Sciences, Logan, UT, USA) containing 10% fetal bovine serum (Biologic Industries, Kibbutz Beit Haemek, Israel) and 1% penicillin/streptomycin (Beyotime Institute of Biotechnology, Nanjing, China) at 37 °C in 5% CO2 and 95% humidity. The anoikis-resistance model was established by continuously culturing corresponding parental (P) cells in ultra-low-attachment 6-well plates (Corning, NY, USA) for 7 days, after which they were transferred to standard plates to allow adherence for 24 h. Re-adherent cells were deemed anoikis-resistance [12, 23, 24].
RNA extraction, RNase R treatment, and PCR assays
The total RNA was isolated from the tissue and cell lines using a RNeasy Mini Kit (QIAGEN, Germany) according to the instructions of the manufacturer. RNase R treatment occurred at 37 °C with 3 U/mg of RNase R (Epicenter, WI, USA) for 15 min. Complementary DNA was synthesized using random primers and a PrimeScript RT Master Mix reverse transcription kit (Takara, Dalian, China) or a commercial miRNA reverse transcription PCR kit (Ribo-Bio, Guangzhou, China). Genomic DNA (gDNA) was isolated using a QIAamp DNA Mini Kit (QIAGEN, Germany), while quantitative real-time PCR (qRT-PCR) analysis was performed using an SYBR Premix Ex TaqTM kit (Takara). The differences between the circRNA and miRNA were normalized to GAPDH or U6 levels. All data were analyzed using the StepOnePlus Real-Time PCR System (Applied Biosystems, Carlsbad, CA, USA). Bulge-loop miRNA qPCR primers were obtained from RiboBio (Guangzhou, China). The primer details are listed in Supplementary Table 1.
RNA-fluorescence in situ hybridization (FISH)
Cy3-labeled circ_0004585 and Dig-labeled locked nucleic acid miR-1248 probes were purchased from RiboBio (Guangzhou, China). The images were obtained using a fluorescent in situ hybridization kit (RiboBio) according to the instructions of the manufacturer. All data were analyzed using a Nikon A1Si laser scanning confocal microscope (Nikon Instruments Inc., Japan) and ModFit LT software.
Pull-down assay with a biotinylated-A probe
The biotinylated-circ_0004585 probe was synthesized by RiboBio (Guangzhou, China). The sequence of the probe was just complemented to the back-spliced junction of circ_0004585 (listed in Supplementary Table 4). The pull-down assay with biotinylated miRNA was performed as previously described [25, 26] The RNA complexes combined on the beads were finally extracted using an RNeasy Mini Kit (QIAGEN, China) for further assessment. The pull-down assay with biotinylated miRNA miR-1248 mimics or mutants was synthesized by RiboBio (Guangzhou, China), while the bound RNAs were purified using a RNeasy Mini Kit (QIAGEN) for further analysis.
Non-transfected cell apoptosis was detected using FITC V Apoptosis and PE Annexin V Apoptosis Detection Kits (BD Biosciences, Franklin Lakes, NJ, USA). Briefly, cells (5 × 105) were collected and incubated with FITC/propidium iodide (PI) for 15 min in the dark at room temperature, while the apoptosis index was determined using a flow cytometer (Beckman Coulter, Indianapolis, IN, USA). For the detachment-induced apoptosis assay, cells were incubated in ultra-low-attachment plates for 24 h before detection. PC-3 and DU145 cells were treated with 200 nM rapamycin (Rapa), or 10 mM 3-methyladenine (3-MA) (Selleck Chemicals, Houston, TX, USA) and 10 μM Chloroquine (CQ) (Selleck Chemicals, Houston, TX, USA) for 24 h, respectively, while isometric double-distilled water or DMSO was used as negative controls (NC). The reagents and drugs used in the study are detailed in Supplementary Table 2.
Wound healing assay
PC-3 and DU145 cells were cultured in 6-well plates and scraped with the fine end of a 200 μl pipette tip (time 0 h). The cell migration was photographed 0 h and 24 h after injury using ten high-power fields. Remodeling was measured as the diminishing distance across the induced injury, normalized to the 0 h control, and expressed as relative migration.
Transwell migration and Matrigel invasion assays
The cell migration was evaluated using a 24-well Transwell plate with 8.0-mm pore polycarbonate membrane inserts (Corning). Homogeneous single-cell suspensions (200 μl; 1 × 105 cells/well) in serum-free mediums were added to the upper chambers, while 500 μl complete mediums were added to the lower chambers. After incubation for 24 h at 37 °C in a CO2 incubator, the migrated or invaded cells were fixed with ice-cold methanol and stained with 0.1% crystal violet for 15 min at room temperature. The migrated cells were counted in three randomly chosen fields using an inverted phase-contrast microscope (Olympus, Tokyo, Japan) at 100× magnification.
Cell Counting Kit-8 (CCK-8) assay
The cell viability was determined using a CCK-8 assay (Supplementary Table 2). The PCa cells were starved in a medium containing 0.1% fetal bovine serum for 24 h. Next, approximately 2 × 103 cells were evenly seeded into 96-well plates in triplicate. Then, CCK-8 solution (10 μl) was added to each well and incubated at 37 °C for 2.5 h. The OD value was measured at 450 nm after 1 d, 2 d, 3 d, 4 d, and 5 d, respectively, using a SpectraMax M5 microplate reader (MD, USA). The cell doubling times were calculated using GraphPad Prism 7.0 software (La Jolla, USA), while the OD values were used to perform the statistical analysis.
Immunofluorescence staining assay
The mCherry-GFP co-labeled LC3BII/I adenovirus (Beyotime) was transferred to PCa cells in different treatment groups for 24 h . Autophagy flux were detected in 2D culture, and a total of more than 20 cells under each condition were counted for quantification of autophagy and the images were amplified by 200 times. and the images were magnified 600 times. The nuclei were stained with DAPI, and the data were analyzed using a Nikon A1Si laser scanning confocal microscope (Nikon Instruments Inc., Japan).
Transmission electron microscopy (TEM)
The cells were collected and fixed with 2.5% glutaraldehyde (Sigma, G7526) at 4 °C for 2 h. TEM of the autophagic and autolysosome ultrastructures in the cells was performed as described in a previous study . The images were acquired using an 11-megapixel CCD camera (Olympus, Japan).
The primary antibody used to detect TM9SF4 was purchased from the Proteintech Group (Chicago, USA). The immunostaining images were captured using an Olympus FSX100 microscope (Olympus, Japan). The immunohistochemical expression level of TM9SF4 was evaluated by H-score, which was jointly completed by two pathologists in our hospital. The protein expression levels were analyzed by calculating the integrated optical density as described .
Luciferase reporter assays
The TM9SF4 3′-UTR or promoter reporters were transiently transfected along with the Renilla control plasmid, while the PCa cells were co-transfected with miR-1248 mimics. The luciferase activities were measured for 24 h using a dual-luciferase reporter assay detection kit (Promega, WI, USA) as previously described .
Plasmid construction and stable transfection
The human circ_0004585 and TM9SF4 3′-UTR cDNA was synthesized by TSINGKE (Wuhan, China). Circ_0004585 was cloned into a pCD-ciR vector (Geenseed Biotech Co, Guangzhou, China) containing front and rear circular frames. The TM9SF4 3′-UTR was cloned into a pMIR-REPORT vector. The T1 and T2 TM9SF4 3′-UTR plasmids and mutant luciferase reporters were synthesized using a Trelief™ SoSoo Cloning Kit (TSINGKE, Beijing, China). The TM9SF4 promoter-luciferase reporter vector was constructed and used as described in previous studies . The miR-1248 mimics and the control were purchased from RiboBio (Guangzhou, China), while the siRNA aimed at circ_0004585 was synthesized by Gene-Pharma (Shanghai, China). The shRNA targeting TM9SF4 was designed and synthesized by Genechem (Shanghai, China). The targeted sequence was in Supplementary Table 5. while Lipofectamine 2000 (Life Technologies, USA) was used for plasmid transfection according to the instructions of the manufacturer. The transfected PCa cells were screened for four to six weeks using G418 (Life Technologies, USA).
The cell lysates were prepared with RIPA buffer (Thermo Scientific), the concentration of which was determined using a bicinchoninic acid protein assay kit (Pierce, Thermo Scientific). The immunoreactive bands were determined with an Immobilon ECL substrate kit (Millipore, Merck KGaA, Germany), while the images were acquired using a BioSpectrum 600 Imaging System (UVP, CA, USA). Detailed information regarding the primary antibodies used in this study is listed in Supplementary Table 3.
Four- to five-week-old male BALB/c nude mice were selected for the tumor xenograft experiments. PC-3 cells, labeled with Cy3 and transfected with overexpressed or knockdown circ_0004585 plasmids or control vectors, were subcutaneously injected into the tail veins of the mice (3 × 106, 200 μl), who were sacrificed after six to seven weeks. No blinding occurred during the animal experiments. Xenograft images of the mice were obtained using the In-Vivo FX PRO (BRUKER Corporation, USA). All procedures were approved by the Animal Care Committee of Tongji Medical College.
Statistical analysis of the data was performed using GraphPad Prism 7.0 software (La Jolla, USA), and the results were expresses as mean ± standard error of the mean (SEM). The two groups were compared via a two-tailed Student’s t-test. One-way analysis of variance was performed to evaluate the group differences, while P < 0.05 was considered statistically significant.
Circ_0004585 is upregulated in the PCa tissues and cell lines and is mainly distributed in the cytoplasm
First, the analysis of the circRNA sequencing databases, circInteractome, circBase, and circRNADb, showed that circ_0004585 was derived from the CEMIP gene (Fig. 1A). qPCR was used to measure the circ_0004585 expression in the parental and anoikis-resistant PCa cells, as well as ten PCa tissue samples and the corresponding adjacent normal tissue. The results showed that circ_0004585 expression was markedly upregulated in the anoikis-resistant PCa cells and PCa tissues compared with the parental PCa cells and adjacent normal tissue (Fig. 1B-C). Moreover, the circular CEMIP product was amplified with divergent primers and confirmed via Sanger sequencing (Fig. 1D). Next, the convergent and divergent primers were designed based on the cDNA and gDNA of the PC-3 and DU145 cell lines to amplify the linear and circRNA. Circ_0004585 was amplified by the divergent cDNA primers, while the gDNA yielded no amplification product (Fig. 1E). Real-time qPCR confirmed circ_0004585 resistance to RNase R, while the CEMIP mRNA was significantly reduced after RNase R treatment (Fig. 1F). RNA-FISH assays were then performed to identify the subcellular circ_0004585 localization using a specific Cy3-labeled probe. The images indicated that circ_0004585 was mainly localized in a punctate pattern in the cytoplasm (Fig. 1G). In addition, Supplementary Fig. 1 confirms that the ability of anoikis-resistance and migration in PCa-AR cells was significantly improved compared with PCa-P cells. These above results demonstrated that circ_0004585 was overexpressed in the PCa tissues and anoikis-resistant PCa cells and predominantly localized in the cell cytoplasm.
Circ_0004585 promotes the autophagy and metastasis of PCa cells in vitro and in vivo
Circ_0004585-overexpressing (circ_0004585) and circ_0004585-knockdown (circ_0004585-sh#1 and circ_0004585-sh#2) PC-3 and DU145 cell lines were established to investigate the impact of circ_0004585 on PCa cells migration, anoikis, and autophagy. The shRNA sequence is shown in Fig. 2A. Then, qRT-PCR was used to detect the circ_0004585 mRNA level in the PCa cells with stably overexpressed or downregulated circ_0004585 (Fig. 2B). In addition, the autophagic flux in the PCa cells expressing endogenous LC3BII/I tagged with tandem fluorescent-mCherry-GFP as a reporter was monitored to observe the autophagic changes in non-adherent conditions. GFP and mCherry signal colocalization (yellow dots) indicated the lack of phagophore or autophagosome fusion with lysosomes. As shown in Fig. 2C, more yellow puncta were evident after circ_0004585 overexpression in the PCa cells following detachment from the ECM for 24 h, while circ_0004585 downregulation reversed this effect. These results were further verified via TEM, revealing the presence of more double-membrane autophagosomes filled with degraded organelles and autolysosomes in the overexpressed circ_0004585 PCa cells (Fig. 2D). Then, the apoptosis level was assessed via flow cytometry to further determine the role of circ_0004585 during the anoikis process. The apoptosis rate of the downregulated circ_0004585 cells was significantly higher than the overexpressed circ_0004585 PCa cells in suspension conditions (Supplementary Fig. 2A). Moreover, wound healing assays showed that cells with significant circ_0004585 expression exhibited high mobility (Supplementary Fig. 2B). Similarly, the transwell assay indicated that circ_0004585 overexpression significantly enhanced the migration capacity of the PCa cells while reducing this trait in the circ_0004585-knockdown PCa cells (Supplementary Fig. 2C). To further confirm the role of circ_0004585 overexpression in PCa cells autophagic activation, anoikis resistance, and metastasis, the autophagic activator, rapamycin (Rapa), or the autophagic inhibitors, chloroquine (CQ) and 3-Methyladenine (3-MA), were added to PCa cells displaying stable circ_0004585 overexpression. Western blotting (Supplementary Fig. 2D), flow cytometry (Supplementary Fig. 2E), and transwell assays (Supplementary Fig. 2F) jointly and fully verified that circ_0004585 overexpression promoted the anoikis resistance and metastasis of PCa cells by activating protective autophagy. Furthermore, the autophagic activator, rapamycin, enhanced the biological effect, while autophagic inhibitors (CQ and 3-MA) achieved the opposite. To further investigate the impact of circ_0004585 on PCa cells metastasis in vivo, athymic nude mice, injected via the tail veins with PC-3 cells stably transfected with circ_0004585, displayed a higher number of metastatic pulmonary colonies, while their survival rate decreased (Fig. 2E-G). Therefore, all above the results confirmed that circ_0004585 overexpression promoted PCa cells anoikis resistance and metastasis by activating protective autophagy.
Circ_0004585 directly interacts with miR-1248 in anoikis-resistant PCa cells
A circ_0004585 probe was constructed to clarify the propagative effect of circ_0004585 on PCa cells invasion and metastasis. Figure 3A presents a schematic representation of the probe sites specific to the back-splice junction of circ_0004585. The gel electrophoretic and qRT-PCR results provided in Fig. 3B, C showed that the circ_0004585 probe could specifically enrich circ_0004585. An ago2-RIP assay was conducted to search for genes binding to circ_0004585. The results showed that among the candidate miRNAs, miR-1248 was pulled down with the anti-ago2 antibody more effectively in the overexpressed circ_0004585 group than in the control (Fig. 3D). The qRT-PCR assay confirmed that circ_0004585 was enriched by biotinylated wild-type miR-1248 (Bio-1248-wt) rather than its mutant (Bio-1248-mut) in the PCa-AR cells, further verifying circ_0004585 and miR-1248 binding (Fig. 3E). The RNA-FISH images in Fig. 3F illustrated circ_0004585 and miR-1248 colocalization in the cytoplasm of the PC-3 cells (the circ_0004585 probe was labeled with Cy3, the locked nucleic acid miR-1248 was labeled with Dig, and the nuclei were stained with DAPI). These results suggest that circ_0004585 functions as a ceRNA for the miR-1248 in PCa cells.
Circ_0004585 binds miR-1248 to upregulate the transcriptional activity of TM9SF4 and promote cell invasion in anoikis-resistant PCa cells
The potential functional role of miR-1248 in PCa was assessed. The transwell migration and wound healing assays of PC-3 and DU145 transfected with miR-1248 mimics alone or cotransfected with circ_0004585 showed that enforced circ_0004585 expression significantly promoted PC-3 and DU145 cell migration, while miR-1248 mimic transfection had the opposite effect (Fig. 4A, B). To further confirm the effect of circ_0004585 binds miR-1248 on apoptosis of PCa, flow cytometry revealed that overexpression of circ_0004585 significantly promoted PCa cells anoikis-resistance. However, upregulated miR-1248 reversed this effect to a great extent (Fig. 4C). The autophagic-related TM9SF4 gene was predicted and determined using three databases (TargetScan, miRDB, and PicTarBase) to further examine the miR-1248 gene (Fig. 4D). The promoter regions and 3′-UTR-related luciferase reporters of TM9SF4 were constructed to provide further clarification regarding miR-1248-enhanced TM9SF4 expression. Figure 4E presents a schematic graph of the potential binding site mutants of miR-1248 and TM9SF4. Mut #1 and Mut #2 represented potentially mutated binding sites 1 and 2, while Mut #3 signified both potentially mutated binding regions. The results of a dual-luciferase reporter assay indicated a significant decline in the luciferase activity of the wild-type TM9SF4 3′-UTR reporter when the PCa cells were transfected with miR-1248 mimics. However, this effect was not observed in the mutated TM9SF4 3′-UTR, indicating that miR-1248 could bind directly to the TM9SF4 3′-UTR region, inhibiting its activity (Fig. 4F). Furthermore, western blot analysis showed that TM9SF4 expression was inhibited by miR-1248 upregulation and enhanced by miR-1248 inhibitor transfection (Fig. 4G). Therefore, the results revealed that circ_0004585 acted as a sponge for miR-1248 to upregulate the transcriptional activity of TM9SF4 and promote PCa cells invasion and anoikis-resistance.
TM9SF4 overexpression is correlated with unfavorable pathological characteristics in PCa
Next, the TM9SF4 expression in PCa and its influence on PCa progression were explored. In this study of disease-specific survival curve, the cut-off value of TM9SF4 (11.36) was used to distinguish between low expression (less than the cut-off value) and high expression (greater than or equal to the cut-off value). The research databases, TCGA (https://www.cancer.gov/tcga) and GEO, GSE6956, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE6956 jointly revealed significant TM9SF4 overexpression in PCa and were closely associated with the poor prognosis of PCa patients (Fig. 5A-C). The TM9SF4 expression was determined via the immunohistochemical staining of 60 paired paraffin-embedded PCa and adjacent tissues to further validate its pathological and clinical significance. Predominant TM9SF4 expression was evident in the cytoplasm, which was distinctly higher in the PCa tissues than in the normal paracancerous tissues (Fig. 5D, E). The TM9SF4 protein levels were significantly elevated in ten pairs of PCa tissues (Fig. 5F). The TM9SF4 expression in the prostate epithelial cells (RWPE-1) and several well-known metastatic cell lines (LNCaP, 22RV1, PC-3, and DU145) was determined via western blot analysis to explore the in vitro results. As expected, the metastatic PCa cells exhibited higher TM9SF4 protein levels than the RWPE-1 cells (Fig. 2G). What’s more, TM9SF4 is overexpression in PCa-AR cells compared with PCa-P cells (Fig. 2H). The correlation between the TM9SF4 expression and clinicopathological characteristics was analyzed, showing that TM9SF4 expression was positively correlated with the clinical PCa stage (I + II versus III + IV, P = 0.0364) (Table 1). Additionally, correlation analysis confirmed a significantly positive relationship between circ_0004585 and TM9SF4 (Fig. 5I). Moreover, although circ_0004585 expression substantially promoted TM9SF4 expression, a significant inhibitory effect was apparent in the presence of miR-1248 overexpression (Fig. 5J). In conclusion, these results suggested that the circ_0004585-regulated TM9SF4 expression in PCa is closely associated with poor prognosis.
TM9SF4 activates autophagy by inhibiting mTOR phosphorylation to promote PCa cell anoikis-resistance and metastasis
Stable overexpressed and knockdown TM9SF4 PCa cells were constructed to further examine the mechanisms underlying anoikis resistance and autophagic TM9SF4 regulation. First, qRT-PCR was used to detect the PCa cell mRNA levels after TM9SF4 overexpression and knockdown (Supplementary Fig. 3A). Next, the western blot assay revealed that TM9SF4 overexpression activated autophagy by inhibiting mTOR (Supplementary Fig. 3B). However, TM9SF4 knockdown facilitated the significant activation of the mTOR pathway by promoting mTOR phosphorylation to inhibit autophagy (Fig. 6A). As shown in Fig. 6B, the overexpressed circ_0004585 and miR-1248 plasmids were cotransfected to confirm the role of circ_0004585 in the mTOR pathway. The overexpression of circ_0004585 significantly inhibited the mTOR pathway, a phenomenon that was reversed by miR-1248 overexpression. In addition, the TM9SF4 knockdown and overexpressed miR-1248 plasmids in the PCa cells were subjected to further co-transfection, revealing that the upregulated miR-1248 inhibition of the mTOR pathway was significantly reversed by TM9SF4 knockdown (Fig. 6C). The autophagic flux was monitored in the PC-3 cells exhibiting TM9SF4 overexpression and downregulation to examine the autophagic changes in non-adherent conditions. As shown in Fig. 6D and Supplementary Fig. 3C, the autophagic flux level of the overexpressed TM9SF4 PC-3 cells increased significantly while declining substantially in the TM9SF4 knockdown PC-3 cells. Furthermore, the number of autophagosomes observed via TEM displayed the same effect in Fig. 6E and Supplementary Fig. 3D. Moreover, the autophagic activator, rapamycin, significantly increased TM9SF4-activated autophagy (P62, LC3BII/I), while this process was substantially restricted by the autophagic inhibitor, 3-MA (Fig. 6F). Next, the effect of the autophagic level on PCa cells anoikis was investigated. The cell viability rate was determined using CCK-8 after individually adding rapamycin or 3-MA to the PCa cells displaying stable TM9SF4 overexpression and knockdown. The rapamycin promoted PCa cells anoikis resistance, while a contradictory effect was achieved by 3-MA (Fig. 6F and Supplementary Fig. 3E). Moreover, flow cytometry demonstrated that rapamycin activated autophagy to reduce apoptosis in the upregulated TM9SF4 PC-3 cells, while 3-MA significantly promoted apoptosis by inhibiting autophagy (Fig. 6G and Supplementary Fig. 3F). In addition, the transwell assay confirmed that TM9SF4 overexpression promoted PCa cells migration (Supplementary Fig. 3G). Therefore, these results confirmed that upregulated TM9SF4 promoted PCa cells anoikis-resistance and metastasis by inhibiting mTOR phosphorylation to facilitate autophagic activation.
CircRNAs are a class of endogenous non-coding RNAs characterized by their covalently closed-loop structures , the abundance and diversity of which in mammalian cells have been confirmed by recent studies . Hundreds of circRNAs reportedly function as vital tumorigenic drivers or tumor suppressors in human cancers . For example, circPLCE1 is downregulated in colorectal carcinoma tissues and is correlated with advanced clinical stages and poor survival . However, significantly higher circURI1 expression is evident in gastric cancer than in the corresponding adjacent nontumor specimens, inhibiting cell migration and invasion in vitro and gastric cancer metastasis in vivo . Previous studies by our team have shown that CEMIP is upregulated in PCa and promotes PCa cell anoikis-resistance via autophagic activation . This study further explored the role of CEMIP and circCEMIP (hsa_circ_0004585) cyclization products in PCa progression, revealing that circCEMIP was significantly upregulated in the PCa tissues and cell lines. Both in vivo and in vitro experiments indicated that circ_0004585 promoted PCa cell anoikis-resistance and metastasis, which could play an important oncogenic role in PCa while showing promise as a novel target for future PCa therapy. However, compared with linear mRNA, circRNA is more stable and easier to detect in cells, plasma, and even circulating exosomes [36,37,38]. Therefore, although further validation is required, circ_0004585 can possibly be used for the PCa diagnosis and prognosis evaluation.
Studies have suggested that circRNAs act as miRNA sponges and display the following characteristics: First, they are derived from one or more exons of known protein-coding genes via back-splicing . Second, these circRNAs are predominantly found in the cytoplasm, similar to miRNAs [39, 40]. Finally, circRNAs with more predictive putative miRNA binding sites are likely to act as ceRNA for miRNA . This study has shown that circ_0004585, derived from 13 CEMIP gene exons and primarily located in the cytoplasm, can combine with miR-1248 to regulate downstream target genes and promote protective autophagy in PCa cells. Furthermore, circ_0004585 overexpression significantly promotes the lung metastasis of PCa in vivo, while circ_0004585 downregulation significantly reverses this effect. However, whether circ_0004585 is involved in other biological processes, such as RNA protein binding [42,43,44] or peptide translation [45, 46], requires further confirmation.
Aberrant miRNA expression in various types of human cancer is pivotal during tumorigenesis, progression, and metastasis [47, 48]. Although miR-1248 is reportedly closely associated with the progression and prognosis of multiple types of cancer, including lung cancer [49, 50] and PCa , its specific role in PCa remains unclear. This study preliminarily confirmed that circ_0004585 promoted PCa cell autophagy and anoikis-resistance via miR-1248 sponging and binding, while miR-1248 overexpression reversed this biological effect. Therefore, this study revealed that miR-1248 inhibited PCa progression and metastasis, presenting a potential therapeutic target, but its specific regulatory mechanism requires further investigation.
TM9SF4, also known as TM9SF or nonaspanins, belongs to the transmembrane 9 protein family  and participates in cell adhesion, phagocytosis, and autophagy [53,54,55]. TM9SF4 is reportedly involved in the cannibalistic activity of metastatic melanoma cells and the resistance of colon cancer cells to chemotherapy by promoting the acidification of the tumor environment on the interior and exterior of the cell [56, 57]. However, no research is available regarding the biological functions of TM9SF4 in PCa. This study confirmed the significant overexpression of TM9SF4 in PCa, which was closely related to its clinical grade and poor prognosis. Moreover, TM9SF4 overexpression promoted PCa cell anoikis-resistance by inhibiting mTOR activity to facilitate autophagy, while the miR-1248 transcriptional regulation of TM9SF4 significantly promoted this effect. The inactivation of the mTOR pathway was essential for autophagic activation, providing energy support for PCa cell anoikis resistance and metastasis . Furthermore, circ_0004585 encouraged PCa progression via miR-1248 sponging, promoting TM9SF4 expression. The comprehensive in vitro and in vivo experiments in this study revealed that circ_0004585 promoted TM9SF4 transcription via miR-1248 sponging, inhibiting mTOR phosphorylation to facilitate protective autophagy and anoikis-resistance in PCa cells. However, many aspects in this study remain unclear and require further exploration. For example, future research should clarify whether additional circCEMIP regulatory mechanisms are involved in PCa progression and find a balance between the protective and damaging impact of autophagy in PCa. Other issues requiring attention involve the exact regulation of mTOR phosphorylation and activity by TM9SF4 and whether additional TM9SF4 regulatory mechanisms are involved in PCa progression. The clarification of these issues denotes the objectives of our future research.
In conclusion, this study reveals that the novel circRNA, circ_0004585, is upregulated in PCa tissues and cell lines, promoting PCa cell anoikis-resistance and metastasis both in vitro and in vivo. Moreover, circ_0004585 upregulated TM9SF4 to inhibit mTOR activity by binding miR-1248 to activate autophagy. Therefore, the results clarify the potential circRNA-related mechanisms behind PCa cell anoikis-resistance regulation while highlighting circ_0004585 as a promising therapeutic target for PCa treatment.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Quantitative real-time PCR
Transmembrane 9 superfamily member 4
Transmission electron microscopy
Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013;1833(12):3481–98.
Du S, Yang Z, Lu X, Yousuf S, Zhao M, Li W, Miao J, Wang X, Yu H, Zhu X, Chen H, Shi L, Xu E, Xia X, Guan W. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling. Oncogene. 2021;40(38):5764-79.
Abe S, Usami S, Nakamura Y. Mutations in the gene encoding KIAA1199 protein, an inner-ear protein expressed in Deiters' cells and the fibrocytes, as the cause of nonsyndromic hearing loss. J Hum Genet. 2003;48(11):564–70.
Yoshida H, Nagaoka A, Nakamura S, et al. N-Terminal signal sequence is required for cellular trafficking and hyaluronan-depolymerization of KIAA1199. FEBS Lett. 2014;588(1):111–6.
Yoshida H, Nagaoka A, Kusaka-Kikushima A, et al. KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. Proc Natl Acad Sci U S A. 2013;110(14):5612–7.
Zhang D, Zhao L, Shen Q, et al. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer. Int J Cancer. 2017;140(10):2298–309.
Matsuzaki S, Tanaka F, Mimori K, et al. Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer. Ann Surg Oncol. 2009;16(7):2042–51.
Evensen NA, Kuscu C, Nguyen HL, et al. Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration. J Natl Cancer Inst. 2013;105(18):1402–16.
Suh HN, Jun S, Oh AY, et al. Identification of KIAA1199 as a Biomarker for Pancreatic Intraepithelial Neoplasia. Sci Rep. 2016;6:38273.
Shostak K, Zhang X, Hubert P, et al. NF-κB-induced KIAA1199 promotes survival through EGFR signalling. Nat Commun. 2014;5:5232.
Gu CJ, Ni QC, Ni K, et al. Expression and clinical significance of KIAA1199 in primary hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi. 2018;98(20):1609–13.
Zhang P, Song Y, Sun Y, et al. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming. FASEB J. 2018;32(7):3924–35.
Yu Y, Liu B, Li X, et al. ATF4/CEMIP/PKCalpha promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells. Cell Death Dis. 2022;13(1):46.
Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–61.
Chen J, Li Y, Zheng Q, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 2017;388:208–19.
Hsiao KY, Lin YC, Gupta SK, et al. Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis. Cancer Res. 2017;77(9):2339–50.
Huang XY, Huang ZL, Xu YH, et al. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinoma. Sci Rep. 2017;7(1):5428.
Zhong C, Wu K, Wang S, et al. Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer. Cell Death Dis. 2021;12(8):726.
Wang K, Sun Y, Tao W, et al. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Lett. 2017;394:1–12.
Yang T, Shen P, Chen Q, et al. FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2021;40(1):261.
Wilusz JE, Sharp PA. Molecular biology. A circuitous route to noncoding RNA. Science. 2013;340(6131):440–1.
Li Y, Chen B, Zhao J, et al. HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein. Adv Sci (Weinh). 2021;8(13):2001701.
Zhang P, Chen L, Song Y, et al. Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK/ERK pathway. Exp Cell Res. 2016;347(2):350–9.
Mawji IA, Simpson CD, Hurren R, et al. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. J Natl Cancer Inst. 2007;99(10):811–22.
Xie F, Li Y, Wang M, et al. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis. Mol Cancer. 2018;17(1):144.
Li Y, Zheng F, Xiao X, et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep. 2017;18(9):1646–59.
Shi S, Tan P, Yan B, et al. ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells. Oncol Rep. 2016;35(5):2606–14.
Koenig U, Robenek H, Barresi C, et al. Cell death induced autophagy contributes to terminal differentiation of skin and skin appendages. Autophagy. 2020;16(5):932–45.
Huang H, Pan X, Jin H, et al. PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a] PDE Exposure. Clin Cancer Res. 2015;21(16):3783–93.
Huang H, Jin H, Zhao H, et al. RhoGDIβ promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation. Mol Oncol. 2017;11(11):1579–94.
Luo G, Liu D, Huang C, et al. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27Kip1. Mol Cancer Res. 2017;15(7):789–99.
Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–8.
Qu S, Liu Z, Yang X, et al. The emerging functions and roles of circular RNAs in cancer. Cancer Lett. 2018;414:301–9.
Liang ZX, Liu HS, Xiong L, et al. A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation. Mol Cancer. 2021;20(1):103.
Gomez JA, Payne A, Pratt RE, Hodgkinson CP, Dzau VJ. A role for Sfrp2 in cardiomyogenesis in vivo. Proc Natl Acad Sci U S A. 2021;118(33).
Li Y, Zheng Q, Bao C, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25(8):981–4.
Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256–64.
Yang C, Yuan W, Yang X, et al. Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression. Mol Cancer. 2018;17(1):19.
Zeng K, Chen X, Xu M, et al. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018;9(4):417.
Arnaiz E, Sole C, Manterola L, et al. CircRNAs and cancer: Biomarkers and master regulators. Semin Cancer Biol. 2019;58:90–9.
Han D, Li J, Wang H, et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology. 2017;66(4):1151–64.
Du WW, Fang L, Yang W, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24(2):357–70.
Abdelmohsen K, Panda AC, Munk R, et al. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol. 2017;14(3):361–9.
Ashwal-Fluss R, Meyer M, Pamudurti NR, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66.
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao F, Huang N, Yang X, Zhao K, Zhou H, Huang S, Xie B, Zhang N. Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis. J Natl Cancer Inst. 2018;110(3).
Gu C, Zhou N, Wang Z, et al. circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide. Mol Ther Nucleic Acids. 2018;13:633–41.
Nelson KM, Weiss GJ. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther. 2008;7(12):3655–60.
Berindan-Neagoe I, Monroig PC, Pasculli B, et al. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64(5):311–36.
Xu J, Tian S, Yin Z, et al. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer. Lung Cancer. 2014;85(3):442–8.
Yue Q, Xu Y, Deng X, et al. Circ-PITX1 Promotes the Progression of Non-Small Cell Lung Cancer Through Regulating the miR-1248/CCND2 Axis. Onco Targets Ther. 2021;14:1807–19.
Pudova EA, Krasnov GS, Nyushko KM, et al. miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer. BMC Med Genet. 2020;13(Suppl 8):129.
Fais S, Fauvarque MO. TM9 and cannibalism: how to learn more about cancer by studying amoebae and invertebrates. Trends Mol Med. 2012;18(1):4–5.
Benghezal M, Cornillon S, Gebbie L, et al. Synergistic control of cellular adhesion by transmembrane 9 proteins. Mol Biol Cell. 2003;14(7):2890–9.
Bergeret E, Perrin J, Williams M, et al. TM9SF4 is required for Drosophila cellular immunity via cell adhesion and phagocytosis. J Cell Sci. 2008;121(Pt 20):3325–34.
Sun L, Meng Z, Zhu Y, et al. TM9SF4 is a novel factor promoting autophagic flux under amino acid starvation. Cell Death Differ. 2018;25(2):368–79.
Lozupone F, Perdicchio M, Brambilla D, et al. The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep. 2009;10(12):1348–54.
Lozupone F, Borghi M, Marzoli F, et al. TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells. Oncogene. 2015;34(40):5163–74.
We thank Prof. Xiaoping Zhang and Prof. Jun Zhao (Union Hospital, Wuhan, China) for C4-2 and LNCaP cell lines.
This work was supported by the National Natural Science Foundation of China (grant numbers 81974399, 81772751, and 82103610).
Ethics approval and consent to participate
The study was performed in accordance with the Declaration of Helsinki. All experimental protocols involving human tissues were approved by the Research Ethics Committees of Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, and all patients signed the informed consent. All experiments involving animal were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anoikis-resistant PCa cells enhance the capabilities of survival and migration. Supplementary Figure 2. Circ_0004585 promotes PCa cells migration, invasion, anikis-resistance. Supplementary Figure 3. Upregulation of TM9SF4 promotes the invasion, migration and anoikis-resistance of prostate cancer cells by activating autophagy. Supplementary Table 1. qRT-PCR primer sequences in this study. Supplementary Table 2. Drugs and reagents. Supplementary Table 3. Primary and secondary antibodies. Supplementary Table 4. Probe sequence in this study. Supplementary Table 5. TM9SF4 shRNA sequence in this study.
About this article
Cite this article
Yu, Y., Song, Y., Cheng, L. et al. CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells. J Exp Clin Cancer Res 41, 188 (2022). https://doi.org/10.1186/s13046-022-02381-7